BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petreus T, Cadogan E, Hughes G, Smith A, Pilla Reddy V, Lau A, O'Connor MJ, Critchlow S, Ashford M, Oplustil O'Connor L. Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response. Commun Biol 2021;4:1001. [PMID: 34429505 DOI: 10.1038/s42003-021-02526-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Valle NME, Nucci MP, Alves AH, Rodrigues LD, Mamani JB, Oliveira FA, Lopes CS, Lopes AT, Carreño MNP, Gamarra LF. Advances in Concentration Gradient Generation Approaches in a Microfluidic Device for Toxicity Analysis. Cells 2022;11:3101. [PMID: 36231063 DOI: 10.3390/cells11193101] [Reference Citation Analysis]
2 Osouli-bostanabad K, Puliga S, Serrano DR, Bucchi A, Halbert G, Lalatsa A. Microfluidic Manufacture of Lipid-Based Nanomedicines. Pharmaceutics 2022;14:1940. [DOI: 10.3390/pharmaceutics14091940] [Reference Citation Analysis]
3 Ahmed T. Organ-on-a-chip microengineering for bio-mimicking disease models and revolutionizing drug discovery. Biosensors and Bioelectronics: X 2022;11:100194. [DOI: 10.1016/j.biosx.2022.100194] [Reference Citation Analysis]
4 Ro J, Kim J, Cho YK. Recent advances in spheroid-based microfluidic models to mimic the tumour microenvironment. Analyst 2022;147:2023-34. [PMID: 35485712 DOI: 10.1039/d2an00172a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Komen J, van Neerven SM, Bossink EGBM, de Groot NE, Nijman LE, van den Berg A, Vermeulen L, van der Meer AD. The Effect of Dynamic, In Vivo-like Oxaliplatin on HCT116 Spheroids in a Cancer-on-Chip Model Is Representative of the Response in Xenografts. Micromachines 2022;13:739. [DOI: 10.3390/mi13050739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Trinidad-Calderón PA, López-Castillo LM, Gallegos-Martínez S, Trujillo-de Santiago G, García-Lara S, Álvarez MM. nurP28, a New-to-Nature Zein-Derived Peptide, Enhances the Therapeutic Effect of Docetaxel in Breast Cancer Monolayers and Spheroids. Molecules 2022;27:2824. [PMID: 35566175 DOI: 10.3390/molecules27092824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Alves AH, Nucci MP, Mamani JB, Valle NME, Ribeiro EF, Rego GNA, Oliveira FA, Theinel MH, Santos RS, Gamarra LF. The Advances in Glioblastoma On-a-Chip for Therapy Approaches. Cancers (Basel) 2022;14:869. [PMID: 35205617 DOI: 10.3390/cancers14040869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Doffe F, Fuoco L, Michels J, Jernström S, Tomasi R, Savagner P. Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening. Explor Target Antitumor Ther 2022;3:853-65. [PMID: 36654822 DOI: 10.37349/etat.2022.00117] [Reference Citation Analysis]
9 Wu Y, Zhou Y, Qin X, Liu Y. From cell spheroids to vascularized cancer organoids: Microfluidic tumor-on-a-chip models for preclinical drug evaluations. Biomicrofluidics 2021;15:061503. [PMID: 34804315 DOI: 10.1063/5.0062697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]